{"entity":{"type":"insider","cik":"0001511900","url":"/insider/0001511900","json_url":"/insider/0001511900.json","name":"Broadfin Healthcare Master Fund Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":125,"n_filings":33,"first":"2014-07-23","last":"2021-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Broadfin Healthcare Master Fund Ltd","source":"filing","n_filings":33,"first_seen":"2014-07-23","last_seen":"2021-11-22"}],"transactions":[{"id":4947470,"accession":"0001103021-21-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000120","line_url":"/filing/0001103021-21-000120#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":306000.0,"total_display":"306,000.00","shares_owned_after":5158489.0,"shares_owned_after_display":"5,158,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":5501569,"accession":"0001103021-21-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000114","line_url":"/filing/0001103021-21-000114#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","shares_owned_after":5058489.0,"shares_owned_after_display":"5,058,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-15","scope":"insider"},{"id":5247179,"accession":"0001103021-21-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000110","line_url":"/filing/0001103021-21-000110#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":257800.0,"shares_display":"257,800","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":894566.0,"total_display":"894,566.00","shares_owned_after":4958489.0,"shares_owned_after_display":"4,958,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider"},{"id":4167590,"accession":"0001103021-21-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-3","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":162500.0,"total_display":"162,500.00","shares_owned_after":4655689.0,"shares_owned_after_display":"4,655,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-13","scope":"insider"},{"id":4167588,"accession":"0001103021-21-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-2","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":324000.0,"total_display":"324,000.00","shares_owned_after":4605689.0,"shares_owned_after_display":"4,605,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4167584,"accession":"0001103021-21-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001103021-21-000046","line_url":"/filing/0001103021-21-000046#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":474000.0,"total_display":"474,000.00","shares_owned_after":4505689.0,"shares_owned_after_display":"4,505,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":8473395,"accession":"0000919574-19-007768","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-19-007768","line_url":"/filing/0000919574-19-007768#line-4","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":6320000.0,"total_display":"6,320,000.00","shares_owned_after":2300066.0,"shares_owned_after_display":"2,300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-20","scope":"insider"},{"id":8473388,"accession":"0000919574-19-007768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-19-007768","line_url":"/filing/0000919574-19-007768#line-2","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":4875000.0,"total_display":"4,875,000.00","shares_owned_after":3300066.0,"shares_owned_after_display":"3,300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":8473385,"accession":"0000919574-19-007768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-007768","line_url":"/filing/0000919574-19-007768#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":6.44,"price_display":"6.44","price_state":"stated","total_value":1610000.0,"total_display":"1,610,000.00","shares_owned_after":4050066.0,"shares_owned_after_display":"4,050,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":7967885,"accession":"0000919574-19-007363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-19-007363","line_url":"/filing/0000919574-19-007363#line-4","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":8850000.0,"total_display":"8,850,000.00","shares_owned_after":300066.0,"shares_owned_after_display":"300,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":7967883,"accession":"0000919574-19-007363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-19-007363","line_url":"/filing/0000919574-19-007363#line-3","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293757.0,"shares_display":"293,757","price_per_share":5.9034,"price_display":"5.90","price_state":"stated","total_value":1734165.0738,"total_display":"1,734,165.07","shares_owned_after":1800066.0,"shares_owned_after_display":"1,800,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":7967876,"accession":"0000919574-19-007363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-007363","line_url":"/filing/0000919574-19-007363#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2206243.0,"shares_display":"2,206,243","price_per_share":6.037,"price_display":"6.04","price_state":"stated","total_value":13319088.991,"total_display":"13,319,088.99","shares_owned_after":2093823.0,"shares_owned_after_display":"2,093,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider"},{"id":7887317,"accession":"0000919574-19-003369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-003369","line_url":"/filing/0000919574-19-003369#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800000.0,"shares_display":"1,800,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","shares_owned_after":4281943.0,"shares_owned_after_display":"4,281,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8697059,"accession":"0000919574-19-002943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-002943","line_url":"/filing/0000919574-19-002943#line-1","is_derivative":false,"issuer_cik":"0001103021","issuer_name":"BIODELIVERY SCIENCES INTERNATIONAL INC","issuer_ticker":"BDSI","issuer_name_source":null,"issuer_url":"/issuer/0001103021","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":4281943.0,"shares_owned_after_display":"4,281,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-11","filed_date":"2019-04-15","scope":"insider"},{"id":6382569,"accession":"0000919574-18-008175","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-11","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.8514,"price_display":"0.85","price_state":"stated","total_value":85140.0,"total_display":"85,140.00","shares_owned_after":1498553.0,"shares_owned_after_display":"1,498,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-27","scope":"insider"},{"id":6382566,"accession":"0000919574-18-008175","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-10","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56316.0,"shares_display":"56,316","price_per_share":0.8548,"price_display":"0.85","price_state":"stated","total_value":48138.9168,"total_display":"48,138.92","shares_owned_after":1598553.0,"shares_owned_after_display":"1,598,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-27","scope":"insider"},{"id":6382563,"accession":"0000919574-18-008175","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-9","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":0.8803,"price_display":"0.88","price_state":"stated","total_value":13028.44,"total_display":"13,028.44","shares_owned_after":1654869.0,"shares_owned_after_display":"1,654,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-27","scope":"insider"},{"id":6382514,"accession":"0000919574-18-008175","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-8","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109900.0,"shares_display":"109,900","price_per_share":0.872,"price_display":"0.87","price_state":"stated","total_value":95832.8,"total_display":"95,832.80","shares_owned_after":1741359.0,"shares_owned_after_display":"1,741,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382511,"accession":"0000919574-18-008175","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-7","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83245.0,"shares_display":"83,245","price_per_share":0.9784,"price_display":"0.98","price_state":"stated","total_value":81446.908,"total_display":"81,446.91","shares_owned_after":1863709.0,"shares_owned_after_display":"1,863,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382508,"accession":"0000919574-18-008175","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-6","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30726.0,"shares_display":"30,726","price_per_share":0.907,"price_display":"0.91","price_state":"stated","total_value":27868.482,"total_display":"27,868.48","shares_owned_after":1669669.0,"shares_owned_after_display":"1,669,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382506,"accession":"0000919574-18-008175","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-5","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28745.0,"shares_display":"28,745","price_per_share":0.9058,"price_display":"0.91","price_state":"stated","total_value":26037.221,"total_display":"26,037.22","shares_owned_after":1700395.0,"shares_owned_after_display":"1,700,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382503,"accession":"0000919574-18-008175","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-4","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12450.0,"shares_display":"12,450","price_per_share":0.9078,"price_display":"0.91","price_state":"stated","total_value":11302.11,"total_display":"11,302.11","shares_owned_after":1851259.0,"shares_owned_after_display":"1,851,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382501,"accession":"0000919574-18-008175","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-3","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12219.0,"shares_display":"12,219","price_per_share":0.9091,"price_display":"0.91","price_state":"stated","total_value":11108.2929,"total_display":"11,108.29","shares_owned_after":1729140.0,"shares_owned_after_display":"1,729,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382498,"accession":"0000919574-18-008175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-2","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":0.9325,"price_display":"0.93","price_state":"stated","total_value":1119.0,"total_display":"1,119.00","shares_owned_after":1946954.0,"shares_owned_after_display":"1,946,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-27","scope":"insider"},{"id":6382494,"accession":"0000919574-18-008175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-008175","line_url":"/filing/0000919574-18-008175#line-1","is_derivative":false,"issuer_cik":"0000827809","issuer_name":"NOVELION THERAPEUTICS INC.","issuer_ticker":"NVLN","issuer_name_source":null,"issuer_url":"/issuer/0000827809","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares, without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":392.0,"total_display":"392.00","shares_owned_after":1948154.0,"shares_owned_after_display":"1,948,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-24","filed_date":"2018-12-27","scope":"insider"},{"id":6601386,"accession":"0000919574-18-003940","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940#line-5","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":282500.0,"total_display":"282,500.00","shares_owned_after":2073025.0,"shares_owned_after_display":"2,073,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider"},{"id":6601383,"accession":"0000919574-18-003940","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940#line-4","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45700.0,"shares_display":"45,700","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":274200.0,"total_display":"274,200.00","shares_owned_after":2123025.0,"shares_owned_after_display":"2,123,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider"},{"id":6601380,"accession":"0000919574-18-003940","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940#line-3","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":227620.0,"total_display":"227,620.00","shares_owned_after":2168725.0,"shares_owned_after_display":"2,168,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider"},{"id":6601377,"accession":"0000919574-18-003940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940#line-2","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29300.0,"shares_display":"29,300","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":171112.0,"total_display":"171,112.00","shares_owned_after":2206725.0,"shares_owned_after_display":"2,206,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider"},{"id":6601374,"accession":"0000919574-18-003940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-003940","line_url":"/filing/0000919574-18-003940#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":137750.0,"total_display":"137,750.00","shares_owned_after":2048025.0,"shares_owned_after_display":"2,048,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-24","filed_date":"2018-05-24","scope":"insider"},{"id":6138614,"accession":"0000919574-18-002503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-002503","line_url":"/filing/0000919574-18-002503#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":2014000.0,"total_display":"2,014,000.00","shares_owned_after":2236025.0,"shares_owned_after_display":"2,236,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-13","filed_date":"2018-03-15","scope":"insider"},{"id":4105443,"accession":"0000919574-17-008727","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-17-008727","line_url":"/filing/0000919574-17-008727#line-3","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":392000.0,"total_display":"392,000.00","shares_owned_after":2436025.0,"shares_owned_after_display":"2,436,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-21","filed_date":"2017-12-22","scope":"insider"},{"id":4105439,"accession":"0000919574-17-008727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-17-008727","line_url":"/filing/0000919574-17-008727#line-2","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":9.84,"price_display":"9.84","price_state":"stated","total_value":108240.0,"total_display":"108,240.00","shares_owned_after":2476025.0,"shares_owned_after_display":"2,476,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-21","filed_date":"2017-12-22","scope":"insider"},{"id":4105433,"accession":"0000919574-17-008727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-008727","line_url":"/filing/0000919574-17-008727#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN; Broadfin Capital, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","shares_owned_after":2487025.0,"shares_owned_after_display":"2,487,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-20","filed_date":"2017-12-22","scope":"insider"},{"id":4181772,"accession":"0000919574-17-008600","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600#line-5","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9900.0,"shares_display":"9,900","price_per_share":9.84,"price_display":"9.84","price_state":"stated","total_value":97416.0,"total_display":"97,416.00","shares_owned_after":2520262.0,"shares_owned_after_display":"2,520,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-14","scope":"insider"},{"id":4181768,"accession":"0000919574-17-008600","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600#line-4","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8237.0,"shares_display":"8,237","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":80722.6,"total_display":"80,722.60","shares_owned_after":2512025.0,"shares_owned_after_display":"2,512,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-14","scope":"insider"},{"id":4181764,"accession":"0000919574-17-008600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600#line-3","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":490000.0,"total_display":"490,000.00","shares_owned_after":2530162.0,"shares_owned_after_display":"2,530,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":4181760,"accession":"0000919574-17-008600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600#line-2","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","shares_owned_after":2580262.0,"shares_owned_after_display":"2,580,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":4181756,"accession":"0000919574-17-008600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-008600","line_url":"/filing/0000919574-17-008600#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; KOTLER KEVIN; Broadfin Healthcare Master Fund Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":9.89,"price_display":"9.89","price_state":"stated","total_value":989.0,"total_display":"989.00","shares_owned_after":2580162.0,"shares_owned_after_display":"2,580,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":4393144,"accession":"0000919574-17-008511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-008511","line_url":"/filing/0000919574-17-008511#line-1","is_derivative":false,"issuer_cik":"0001511900","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001511900","owner_cik":null,"owner_name":"Broadfin Capital, LLC; Broadfin Healthcare Master Fund Ltd; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","shares_owned_after":2605262.0,"shares_owned_after_display":"2,605,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-05","filed_date":"2017-12-07","scope":"insider"},{"id":4299699,"accession":"0000919574-17-008470","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-19","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":425298.0,"shares_display":"425,298","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":2296609.2,"total_display":"2,296,609.20","shares_owned_after":4294426.0,"shares_owned_after_display":"4,294,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299696,"accession":"0000919574-17-008470","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-18","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72000.0,"shares_display":"72,000","price_per_share":5.65,"price_display":"5.65","price_state":"stated","total_value":406800.0,"total_display":"406,800.00","shares_owned_after":4784854.0,"shares_owned_after_display":"4,784,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299693,"accession":"0000919574-17-008470","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-17","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":272500.0,"total_display":"272,500.00","shares_owned_after":4721624.0,"shares_owned_after_display":"4,721,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299691,"accession":"0000919574-17-008470","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-16","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8020.0,"shares_display":"8,020","price_per_share":5.53,"price_display":"5.53","price_state":"stated","total_value":44350.6,"total_display":"44,350.60","shares_owned_after":4776834.0,"shares_owned_after_display":"4,776,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299687,"accession":"0000919574-17-008470","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-15","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5110.0,"shares_display":"5,110","price_per_share":5.52,"price_display":"5.52","price_state":"stated","total_value":28207.2,"total_display":"28,207.20","shares_owned_after":4771724.0,"shares_owned_after_display":"4,771,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299684,"accession":"0000919574-17-008470","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-14","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":10336.0,"total_display":"10,336.00","shares_owned_after":4719724.0,"shares_owned_after_display":"4,719,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299680,"accession":"0000919574-17-008470","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-13","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.47,"price_display":"5.47","price_state":"stated","total_value":547.0,"total_display":"547.00","shares_owned_after":4771624.0,"shares_owned_after_display":"4,771,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-01","scope":"insider"},{"id":4299678,"accession":"0000919574-17-008470","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-12","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":595000.0,"total_display":"595,000.00","shares_owned_after":4956854.0,"shares_owned_after_display":"4,956,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"},{"id":4299676,"accession":"0000919574-17-008470","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-11","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":297500.0,"total_display":"297,500.00","shares_owned_after":4906854.0,"shares_owned_after_display":"4,906,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"},{"id":4299673,"accession":"0000919574-17-008470","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000919574-17-008470","line_url":"/filing/0000919574-17-008470#line-10","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":null,"owner_name":"Broadfin Healthcare Master Fund Ltd; Broadfin Capital, LLC; KOTLER KEVIN","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":295000.0,"total_display":"295,000.00","shares_owned_after":4856854.0,"shares_owned_after_display":"4,856,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-01","scope":"insider"}],"next_cursor":"2017-11-30|4299673","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001103021","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","url":"/issuer/0001103021","role":"Director","n_filings":8,"first_seen":"2019-04-15","last_seen":"2021-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000827809","name":"NOVELION THERAPEUTICS INC.","url":"/issuer/0000827809","role":"Ten percent owner","n_filings":1,"first_seen":"2018-12-27","last_seen":"2018-12-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner","n_filings":11,"first_seen":"2014-12-04","last_seen":"2018-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Ten percent owner","n_filings":1,"first_seen":"2017-12-01","last_seen":"2017-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-20","last_seen":"2017-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001594337","name":"Corium International, Inc.","url":"/issuer/0001594337","role":"Ten percent owner","n_filings":3,"first_seen":"2017-10-06","last_seen":"2017-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001012477","name":"AVADEL PHARMACEUTICALS PLC","url":"/issuer/0001012477","role":"Ten percent owner","n_filings":1,"first_seen":"2017-06-26","last_seen":"2017-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Ten percent owner","n_filings":3,"first_seen":"2014-07-23","last_seen":"2017-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Ten percent owner","n_filings":3,"first_seen":"2015-11-13","last_seen":"2016-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001051514","name":"STRATA Skin Sciences, Inc.","url":"/issuer/0001051514","role":"Ten percent owner","n_filings":1,"first_seen":"2016-03-14","last_seen":"2016-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001511900","retrieved_at":"2026-08-21T10:28:43+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}